Metraipolis › archive › dc_6cb19d44869c

An updated meta-analysis of head-to-head trials comparing the efficacy, safety, and adherence of mirabegron and vibegron in overactive bladder — Europe PMC PMID:41366890

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41366890
DOI
10.1097/md.0000000000046109
License (as archived)
solo-consultazione
Archived
2026-11-08T01:35:55.875Z
SHA-256 of the archived text
e378eba81472a280ea09c8b3f8f5ce51bae192f1f512a0f88ef78bc42861fbc2
Stable URL of this page
https://metraipolis.com/documento/dc_6cb19d44869c

How to cite

An updated meta-analysis of head-to-head trials comparing the efficacy, safety, and adherence of mirabegron and vibegron in overactive bladder — Europe PMC PMID:41366890 — Europe PMC (en), https://europepmc.org/article/MED/41366890 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6cb19d44869c (Metraipolis archive dc_6cb19d44869c, sha256 e378eba81472a280ea09c8b3f8f5ce51bae192f1f512a0f88ef78bc42861fbc2)
BibTeX
@misc{dc6cb19d44869c,
  title = {An updated meta-analysis of head-to-head trials comparing the efficacy, safety, and adherence of mirabegron and vibegron in overactive bladder — Europe PMC PMID:41366890},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41366890},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6cb19d44869c; sha256 e378eba81472a280ea09c8b3f8f5ce51bae192f1f512a0f88ef78bc42861fbc2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41366890. Agents can read the archived copy with the MCP tool read_document.